How a specific RNA modification controls GLP-1 hormone release through a protein pathway in type 2 diabetic mice

Attenuated endogenous secretion of glucagon-like peptide-1 (GLP-1) is a defining feature of type 2 diabetes mellitus (T2DM).

• The precise molecular mechanisms behind reduced GLP-1 secretion in T2DM are not fully understood.
• METTL14 is involved in adding a specific chemical marker (N6-methyladenosine) to the long noncoding RNA Gm2824.
• This modification may influence GLP-1 secretion by affecting the YBX1/Foxa1 signaling pathway.
• The study identifies a potential regulatory role of long noncoding RNA in GLP-1 modulation.

Simplified